SECURITY

Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd.: 66 reported NSE/BSE deal sides from 2013-08-29 to 2025-10-16.

Reported purchases₹1,055.85 Cr

Reported sales₹1,636.87 Cr

Disclosed sides66

Recent disclosures

Date	Company	Participant	Side	Shares	Price	Reported value
2025-10-16NSE · Block	Aurobindo Pharma Ltd.	GOLDMAN SACHS BANK EUROPESE - ODI	Buy	106,228	₹1107.00	₹11.76 Cr
2025-10-16NSE · Block	Aurobindo Pharma Ltd.	GOLDMAN SACHS (SINGAPORE) PTE.- ODI	Sell	106,228	₹1107.00	₹11.76 Cr
2024-01-25BSE · Block	Aurobindo Pharma Ltd.	SOCIETE GENERALE	Buy	1,484,323	₹1160.10	₹172.20 Cr
2024-01-25BSE · Block	Aurobindo Pharma Ltd.	BNP PARIBAS ARBITRAGE	Sell	1,484,323	₹1160.10	₹172.20 Cr
2024-01-25BSE · Block	Aurobindo Pharma Ltd.	BNP PARIBAS ARBITRAGE	Sell	150,001	₹1160.10	₹17.40 Cr
2024-01-25NSE · Block	Aurobindo Pharma Ltd.	SOCIETE GENERALE	Sell	107,558	₹1160.10	₹12.48 Cr
2024-01-25BSE · Block	Aurobindo Pharma Ltd.	MARSHALL WACE INVESTMENT STRATEGIES - EUREKA FUND	Buy	106,480	₹1160.10	₹12.35 Cr
2024-01-25NSE · Block	Aurobindo Pharma Ltd.	MARSHALL WACE INVESTMENT STRATEGIES EUREKA FUND	Buy	53,641	₹1160.10	₹6.22 Cr
2024-01-25NSE · Block	Aurobindo Pharma Ltd.	MARSHALL WACE INVESTMENT STRATEGIES TOPS FUND	Buy	44,921	₹1160.10	₹5.21 Cr
2024-01-25BSE · Block	Aurobindo Pharma Ltd.	MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUND	Buy	27,571	₹1160.10	₹3.20 Cr
2024-01-25BSE · Block	Aurobindo Pharma Ltd.	MARSHALL WACE INVESTMENT STRATEGIES - SYSTEMATIC ALPHA PLUS FUND	Buy	15,950	₹1160.10	₹1.85 Cr
2024-01-25NSE · Block	Aurobindo Pharma Ltd.	MARSHALL WACE INVESTMENT STRATEGIES MARKET NEUTRAL TOPS FUND	Buy	8,134	₹1160.10	₹0.94 Cr
2024-01-25NSE · Block	Aurobindo Pharma Ltd.	MARSHALL WACE INVESTMENT STRATEGIES SYSTEMATIC ALPHA PLUS FUND	Buy	862	₹1160.10	₹0.10 Cr
2022-11-14NSE · Block	Aurobindo Pharma Ltd.	ISHARES CORE MSCI EMERGING MARKETS ETF	Buy	297,308	₹489.30	₹14.55 Cr
2022-11-14NSE · Block	Aurobindo Pharma Ltd.	ISHARES CORE EMERGING MARKETS MAURITIUS CO	Sell	297,308	₹489.30	₹14.55 Cr